| 2021-10-21 |
股东大会：
将于2021-11-16召开股东大会
会议内容 ▼▲
- 1.Approve the issuance of shares of common stock of Advaxis to shareholders of Biosight, pursuant to the terms of the Merger Agreement, a copy of which is attached as Annex A to the accompanying proxy statement/prospectus/information statement, and the change of control resulting from the merger;
2.Approve an amendment to the amended and restated certificate of incorporation of Advaxis to effect a reverse stock split of Advaxis’ issued and outstanding common stock within a range, as determined by the Advaxis board of directors and agreed to by Biosight, of one new share of Advaxis common stock for every 10 to 30 shares (or any number in between) of outstanding Advaxis common stock in the form attached as Annex E to the accompanying proxy statement/prospectus/information statement;
3.Approve an amendment to the amended and restated certificate of incorporation of Advaxis to change the corporate name from Advaxis, Inc. to “Biosight Therapeutics Inc.” in the form attached as Annex F to the accompanying proxy statement/prospectus/information statement;
4.Approve, on a non-binding, advisory basis, the compensation that will or may become payable by Advaxis to its named executive officers in connection with the merger;
5.Consider and vote upon an adjournment of the Advaxis special meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1, 2 and 3;
6.Transact such other business as may properly come before the stockholders at the Advaxis special meeting or any adjournment or postponement thereof.
|
| 2021-09-10 |
详情>>
业绩披露：
2021年三季报(累计)每股收益-0.1美元,归母净利润-1241.8万美元,同比去年增长37.94%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-06-14 |
详情>>
股本变动：
变动后总股本14563.85万股
变动原因 ▼▲
- 原因：
- From January 31, 2021 To April 30, 2021
Stock-based compensation
Advaxis public offerings, net of offering costs
Warrant exercises
Issuance of shares to employees under ESPP Plan
|
| 2021-06-14 |
详情>>
业绩披露：
2021年中报每股收益-0.08美元,归母净利润-908.4万美元,同比去年增长35.94%
|
| 2021-04-21 |
股东大会：
将于2021-06-03召开股东大会
会议内容 ▼▲
- 1.To elect six members to our Board to hold office until the next annual meeting of stockholders and until their respective successors have been duly elected and qualified, subject to their earlier resignation or removal (the “Director Election Proposal”).
2.To approve an amendment to our Amended and Restated Certificate of Incorporation (the “Charter’) to increase the number of authorized shares of common stock, $0.001 par value per share from 170,000,000 shares to 300,000,000 shares (the “Authorized Shares Proposal”).
3.To approve an amendment to the Charter to effect a reverse stock split of our common stock at a ratio determined by the Board of Directors within a range of one-to-five to one-for-fifteen, without reducing the authorized number of shares of our common stock, to be effected in the sole discretion of the Board at any time within one year of the date of the 2021 Annual Meeting of Stockholders without further approval or authorization of our stockholders (the “Stock Split Proposal”).
4.To approve an amendment to our 2015 Incentive Plan (the “2015 Incentive Plan”) to increase to increase the existing per-participant annual award limitations included therein (the “Annual Award Limit Proposal”).
5.To ratify and approve the prior amendment to the Company’s 2015 Incentive Plan, which was adopted following the 2020 Annual Meeting of Stockholders (the “2020 Annual Meeting”), to increase the total number of shares of common stock authorized for issuance thereunder from 877,744 shares to 6,000,000 shares (the “Plan Ratification Proposal”).
6.To ratify the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2021, which we refer to as fiscal 2021 (the “Auditor Ratification Proposal”).
|
| 2021-03-16 |
详情>>
业绩披露：
2021年一季报每股收益-0.05美元,归母净利润-397.7万美元,同比去年增长49.38%
|
| 2021-01-22 |
详情>>
业绩披露：
2020年年报每股收益-0.43美元,归母净利润-2646.9万美元,同比去年增长-59.34%
|
| 2020-09-10 |
详情>>
业绩披露：
2020年三季报(累计)每股收益-0.35美元,归母净利润-2000.9万美元,同比去年增长-211.47%
|
| 2020-06-11 |
详情>>
业绩披露：
2020年中报每股收益-0.25美元,归母净利润-1418万美元,同比去年增长-512.93%
|
| 2020-03-20 |
股东大会：
将于2020-05-04召开股东大会
会议内容 ▼▲
- 1.To elect six members to our Board of Directors to hold office until the next annual meeting of stockholders and until their respective successors have been duly elected and qualified, subject to their earlier resignation or removal.
2.To approve an amendment to our 2015 Incentive Plan to increase the total number of shares of common stock authorized for issuance thereunder from 877,744 shares to 6,000,000 shares.
3.To approve an advisory (non-binding) resolution regarding the compensation of our named executive officers.
4.To ratify the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2020, which we refer to as fiscal 2020.
5.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2020-03-13 |
详情>>
业绩披露：
2020年一季报每股收益-0.15美元,归母净利润-785.7万美元,同比去年增长-161.3%
|
| 2019-12-20 |
详情>>
业绩披露：
2019年年报每股收益-1.09美元,归母净利润-1661.2万美元,同比去年增长75.03%
|
| 2019-09-09 |
详情>>
业绩披露：
2019年三季报(累计)每股收益-0.94美元,归母净利润-642.4万美元,同比去年增长86.59%
|
| 2019-06-10 |
详情>>
业绩披露：
2019年中报每股收益0.65美元,归母净利润343.40万美元,同比去年增长110.13%
|
| 2019-05-15 |
复牌提示：
2019-05-15 07:55:00 停牌，复牌日期 2019-05-15 08:30:00
|
| 2019-03-29 |
详情>>
拆分方案：
每15.0000合并分成1.0000股
|
| 2019-01-11 |
股东大会：
将于2019-02-21召开股东大会
会议内容 ▼▲
- 1.To elect six members to our Board of Directors to hold office until the next annual meeting of stockholders and until their respective successors have been duly elected and qualified, subject to their earlier resignation or removal.
2.To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the total number of authorized shares of common stock from 95,000,000 shares to 170,000,000 shares.
3.To approve an amendment to our Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock at a ratio determined by the Board of Directors within a specified range, without reducing the authorized number of shares of our common stock, to be effected in the sole discretion of the Board of Directors at any time within one year of the date of the Annual Meeting without further approval or authorization of our stockholders.
4.To approve an advisory (non-binding) resolution regarding the compensation of our named executive officers.
5.To consider and act upon an advisory (non-binding) vote on the frequency at which we should include an advisory vote regarding the compensation of our named executive officers in future Proxy Statements for stockholder consideration.
6.To ratify the selection of Marcum LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2019, which we refer to as fiscal 2019.
7.Vote on one (1) stockholder proposal contained in the Proxy Statement accompanying this notice, if properly presented by the stockholder proponents at the meeting.
8.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2018-06-07 |
财报披露：
美东时间 2018-06-07 盘前发布财报
|
| 2018-03-12 |
财报披露：
美东时间 2018-03-12 盘后发布财报
|
| 2018-02-06 |
股东大会：
将于2018-03-21召开股东大会
会议内容 ▼▲
- 1. To elect five members to our Board of Directors to hold office until the next annual meeting of stockholders or until their respective successors have been elected and qualified.
2. To approve an amendment to our Amended and Restated Certificate of Incorporation to increase our authorized share capital by 30,000,000 shares of common stock.
3. To approve our 2018 Employee Stock Purchase Plan.
4. To ratify the selection of Marcum LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2018, which we refer to as fiscal 2018.
5. To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2017-12-20 |
财报披露：
美东时间 2017-12-20 盘后发布财报
|
| 2017-02-10 |
股东大会：
将于2017-04-05召开股东大会
会议内容 ▼▲
- 1.To elect eight members to our Board of Directors to hold office until the next annual meeting of stockholders or until their respective successors have been elected and qualified.
2.To approve an amendment to our 2015 Incentive Plan.
3.To ratify 2015 stock option grants under our 2015 Incentive Plan to certain directors and officers.
4.To ratify the selection of Marcum LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2017, which we refer to as fiscal 2017.
5.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2016-02-11 |
股东大会：
将于2016-03-10召开股东大会
会议内容 ▼▲
- 1.To elect nine members to our Board of Directors to hold office until the next annual meeting of stockholders or until their respective successors have been elected and qualified.
2.To approve an amendment to our Amended and Restated Certificate of Incorporation to increase our authorized shares of common stock by 20,000,000 shares from 45,000,000 to 65,000,000.
3.To approve an amendment to our 2015 Incentive Plan to authorize an additional 1,000,000 shares thereunder.
4.To approve an advisory (non-binding) resolution regarding the compensation of our named executive officers.
5.To ratify the selection of Marcum LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2016, which we refer to as fiscal 2016.
6.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2015-04-07 |
股东大会：
将于2015-05-27召开股东大会
会议内容 ▼▲
- 1. To elect seven members to our Board of Directors to hold office until the next annual meeting of stockholders or until their respective successors have been elected and qualified.
2. To approve our 2015 Incentive Plan.
3. To ratify the selection of Marcum, LLP as our independent registered public accountants for the fiscal year ending October 31, 2015, which we refer to as fiscal 2015.
4. To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2014-05-20 |
股东大会：
将于2014-07-09召开股东大会
会议内容 ▼▲
- 1. To elect six members to the Board of Directors to hold office until the next annual meeting of stockholders or until their respective successors have been elected and qualified.
2. To approve an amendment to our Certificate of Incorporation to increase the total number of authorized shares of capital stock from 30,000,000 consisting of 25,000,000 shares of common stock and 5,000,000 shares of “blank check” preferred stock to 50,000,000 consisting of 45,000,000 shares of common stock and 5,000,000 shares of “blank check” preferred stock.
3. To ratify and approve an amendment to our 2011 Omnibus Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 1,600,000 shares.
4. To ratify the selection of Marcum, LLP as our independent registered public accountants for the fiscal year ending October 31, 2014, which we refer to as fiscal 2014.
5. To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2012-11-20 |
详情>>
内部人交易：
BERMAN RICHARD J共交易7笔
|